#candidiasis — Thursday, July 02, 2026 (3 items)
| 0 | ℹ |
Biomarker-driven strategy for early discontinuation of empirical antifungal treatment in critically ill patients: the role of (1-3)-beta-D-glucan using Wako(R) test.
(academic.oup.com)
|
Journal of Antimicrobial Chemotherapy 2026-07-02 | #antifungal #biomarker #candidiasis #stewardship #diagnostics | |
| 0 | ℹ |
Can pharmacokinetic/pharmacodynamic targets be achieved with voriconazole in the treatment of urinary tract infections caused by Candida spp. with reduced susceptibility to fluconazole?
(academic.oup.com)
|
Journal of Antimicrobial Chemotherapy 2026-07-02 | #pharmacokinetics #antifungal #susceptibility #candidiasis #urinary | |
| 0 | ℹ |
Evaluation of an early step-down (</=5 days) strategy from echinocandins to azole therapy for the treatment of invasive candidiasis.
(academic.oup.com)
|
Journal of Antimicrobial Chemotherapy 2026-07-02 | #antifungal #candidiasis #de-escalation #infection |